Acorah Software Products - Accounts Production 16.6.950 true true false true No description of principal activity 23 March 2024 31 March 2025 31 March 2025 15586089 Dr Aulfat Rusool Ali Miss Regina Kazlauskaite Mr David Goode iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15586089 2024-03-22 15586089 2025-03-31 15586089 2024-03-23 2025-03-31 15586089 frs-bus:PrivateLimitedCompanyLtd 2024-03-23 2025-03-31 15586089 frs-bus:FilletedAccounts 2024-03-23 2025-03-31 15586089 frs-bus:Micro-entities 2024-03-23 2025-03-31 15586089 frs-bus:EntityHasNeverTraded 2024-03-23 2025-03-31 15586089 frs-bus:AuditExempt-NoAccountantsReport 2024-03-23 2025-03-31 15586089 frs-bus:Director1 2024-03-23 2025-03-31 15586089 frs-bus:Director2 2024-03-23 2025-03-31 15586089 frs-bus:Director3 2024-03-23 2025-03-31
Registered number: 15586089
Veinology Ltd
Unaudited Financial Statements
For the Period 23 March 2024 to 31 March 2025
AWR Accountants Limited
Veinology Ltd
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15586089

| 31 March 2025
--- | ---
|  | £
Current assets |  | 200
NET CURRENT ASSETS |  | 200
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 200
NET ASSETS |  | 200
CAPITAL AND RESERVES |  | 200

## Notes

1. General Information
Veinology Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15586089 . The registered office is 162 , Nottingham Road, Nottingham, NG9 8AR.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Miss Regina Kazlauskaite Director
08/12/2025